President Joe Biden’s nominee to head the Food and Drug Administration (FDA) is set for a Senate vote next week after the upper chamber’s top Democrat filed cloture on the nomination on Feb. 10.
Senate Majority Leader Chuck Schumer (D-N.Y.) filed cloture on the nomination of Dr. Robert Califf even as some Democrats continued to express opposition to the pick, who isn’t assured a confirmation in the divided Senate.